Association of combination cardiovascular therapies with cognitive decline and neuropathologies
Combination therapies with anti-hypertensive, lipid-lowering, and anti-diabetes medications are associated with slower cognitive decline and less dementia-related neuropathologies. Combination therapies targeting vascular metabolic risk factors have the potential to prevent dementia.
Authors
- Roshni Biswas (ORCID: https://orcid.org/0000-0002-3917-5145)
- Ana W. Capuano (ORCID: https://orcid.org/0000-0002-3505-344X)
- Bennett Da
- Z.O.E. Arvanitakis
- Rupal I. Mehta
Institutions
- Rush University Medical Center (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70860_106195
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00